156 related articles for article (PubMed ID: 32279226)
1. Association between TSHR gene methylation and papillary thyroid cancer: a meta-analysis.
Qu M; Wan S; Ren B; Wu H; Liu L; Shen H
Endocrine; 2020 Sep; 69(3):508-515. PubMed ID: 32279226
[TBL] [Abstract][Full Text] [Related]
2. TSHR rs2288496 associated with thyroid hormone and predict the occurrence of lymph node metastasis of papillary thyroid cancer.
Su X; Lin LW; Weng JL; Chen SW; Yang XH; Zhou DL; Long YK; Shao Q; Ye ZL; Peng JL; Deng L; He CY; Yang AK
Cancer Biomark; 2019; 26(4):461-470. PubMed ID: 31658048
[TBL] [Abstract][Full Text] [Related]
3. Use of Delphian lymph node metastasis to predict central and lateral involvement in papillary thyroid carcinoma: A systematic review and meta-analysis.
Huang J; Sun W; Zhang H; Zhang P; Wang Z; Dong W; He L; Zhang T
Clin Endocrinol (Oxf); 2019 Jul; 91(1):170-178. PubMed ID: 30851206
[TBL] [Abstract][Full Text] [Related]
4. A meta-analysis evaluating the relationship between B-type Raf kinase mutation and cervical lymphatic metastasis in papillary thyroid cancer.
Ma H; Wang R; Fang J; Zhong Q; Chen X; Hou L; Feng L; Chen X; Huang Z; Zhao H
Medicine (Baltimore); 2020 Jan; 99(5):e18917. PubMed ID: 32000400
[TBL] [Abstract][Full Text] [Related]
5. Risk factors of skip lateral cervical lymph node metastasis in papillary thyroid carcinoma: a systematic review and meta-analysis.
Zhao L; Wu F; Zhou T; Lu K; Jiang K; Zhang Y; Luo D
Endocrine; 2022 Feb; 75(2):351-359. PubMed ID: 35067901
[TBL] [Abstract][Full Text] [Related]
6. Methylation status of TSHr in well-differentiated thyroid cancer by using cytologic material.
Kartal K; Onder S; Kosemehmetoglu K; Kilickap S; Tezel YG; Kaynaroglu V
BMC Cancer; 2015 Oct; 15():824. PubMed ID: 26519197
[TBL] [Abstract][Full Text] [Related]
7. Predictive Value of BRAF
Song JY; Sun SR; Dong F; Huang T; Wu B; Zhou J
Curr Med Sci; 2018 Oct; 38(5):785-797. PubMed ID: 30341513
[TBL] [Abstract][Full Text] [Related]
8. Thyroid-stimulating hormone receptor affects metastasis and prognosis in papillary thyroid carcinoma.
Liu TR; Su X; Qiu WS; Chen WC; Men QQ; Zou L; Li ZQ; Fu XY; Yang AK
Eur Rev Med Pharmacol Sci; 2016 Sep; 20(17):3582-91. PubMed ID: 27649658
[TBL] [Abstract][Full Text] [Related]
9. The Role of
Klimaitė R; Kazokaitė M; Kondrotienė A; Daukšienė D; Sabaliauskaitė R; Žukauskaitė K; Žilaitienė B; Jarmalaitė S; Daukša A
J Clin Med; 2022 Aug; 11(16):. PubMed ID: 36013156
[TBL] [Abstract][Full Text] [Related]
10. Organochlorine pesticides and epigenetic alterations in thyroid tumors.
Salimi F; Asadikaram G; Ashrafi MR; Zeynali Nejad H; Abolhassani M; Abbasi-Jorjandi M; Sanjari M
Front Endocrinol (Lausanne); 2023; 14():1130794. PubMed ID: 37560303
[TBL] [Abstract][Full Text] [Related]
11. The relationship between urinary iodine concentration and papillary thyroid cancer: A systematic review and meta-analysis.
Zhang X; Zhang F; Li Q; Aihaiti R; Feng C; Chen D; Zhao X; Teng W
Front Endocrinol (Lausanne); 2022; 13():1049423. PubMed ID: 36387866
[TBL] [Abstract][Full Text] [Related]
12. RASSF1A promoter methylation is associated with increased risk of thyroid cancer: a meta-analysis.
Shou F; Xu F; Li G; Zhao Z; Mao Y; Yang F; Wang H; Guo H
Onco Targets Ther; 2017; 10():247-257. PubMed ID: 28123306
[TBL] [Abstract][Full Text] [Related]
13. [Association of BRAF(V) 600E mutation with clinical pathological features in papillary thyroid carcinoma: meta-analysis].
Yan K; Lin X; Li S; Bao H; Zhao L; Liu X
Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2014 Sep; 49(9):759-64. PubMed ID: 25487587
[TBL] [Abstract][Full Text] [Related]
14. Correlation of thyroid stimulating hormone receptor mRNA expression levels in peripheral blood with undesirable clinicopathological features in papillary thyroid carcinoma patients.
Liu R; Hao S; Zhang H; Ma J; Liu X; Xu J; Liu X; Ning J; Sun Y; Jiang L; Li G; Song X; Zheng H
Oncotarget; 2017 Sep; 8(43):74129-74138. PubMed ID: 29088773
[TBL] [Abstract][Full Text] [Related]
15. Association between Hashimoto thyroiditis and clinical outcomes of papillary thyroid carcinoma: A meta-analysis.
Tang Q; Pan W; Peng L
PLoS One; 2022; 17(6):e0269995. PubMed ID: 35709179
[TBL] [Abstract][Full Text] [Related]
16. Association between
Qian W; Xu K; Jia W; Lan L; Zheng X; Yang X; Cui D
J Biomed Res; 2016 Nov; 30(6):466-475. PubMed ID: 27231040
[TBL] [Abstract][Full Text] [Related]
17. Relationship between VEGF protein expression and lymph node metastasis in papillary thyroid carcinoma among Asians: a meta-analysis.
Chang DF; Xu ZQ; Sun B
Tumour Biol; 2014 Jun; 35(6):5511-8. PubMed ID: 24557543
[TBL] [Abstract][Full Text] [Related]
18. [The clinicopathological associations between TGF-β1 and papillary thyroid carcinoma: a Meta-analysis.].
Xu Y; Ma L; Zhang GA; Wang W; Zhang RY; Hou S; Cui W
Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2017 Sep; 31(18):1431-1435. PubMed ID: 29798000
[No Abstract] [Full Text] [Related]
19. Clinical significance of matrix metalloproteinase-9 expression in papillary thyroid carcinoma: a meta-analysis.
Wen J; Qin X; Zhang J; Wu X; Yan X; Lu K; Yang P; Ji S; Zhao X; Wang Y
World J Surg Oncol; 2023 Jul; 21(1):225. PubMed ID: 37496069
[TBL] [Abstract][Full Text] [Related]
20. Clinicopathological significance of chemokine receptor CXCR4 expression in papillary thyroid carcinoma: a meta-analysis.
Wu Z; Cao Y; Jiang X; Li M; Wang G; Yang Y; Lu K
Minerva Endocrinol; 2020 Mar; 45(1):43-48. PubMed ID: 29424203
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
